Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IOA-289 in combination with gemcitabine/nab-paclitaxel in metastatic pancreatic cancer
NCT05586516Phase 2Completed
- Sponsor
- iOnctura
- Start
- Oct 2022
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of cambritaxestat, sponsored by iOnctura. Started Oct 2022; status: completed.
02
Drugs
cambritaxestat
Beyond the preview
Go deeper on NCT05586516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05586516.